Literature DB >> 276635

Physicochemical properties and isoenzyme composition of hexokinase from normal and malignant human tissues.

N K Monakhov, E L Neistadt, M M Shavlovskil, A L Shvartsman, S A Neĭfakh.   

Abstract

The activity of hexokinase was studied in several normal and malignant human tissues. The enzyme activity in tumors was significantly higher. Isoenzyme studies on normal gastric mucosa and stomach cancer extracts showed that malignancy is accompanied by a "simplification" of the hexokinase isoenzyme pattern due to "deletion" of the slowest isoenzyme. Preparative polyacrylamide gel electrophoreis was used to isolate hexokinase isoenzymes from normal and malignant tissues. Tumor hexokinase isoenzymes displayed an increased affinity to glucose when compared to the corresponding normal prototypes (Km/glucose, 10(-6) M and 10(-5) M, respectively; Km = Michaelis constant). The molecular weights, subunit composition, and peptide patterns were identical for corresponding isoenzyme pairs from normal and tumor tissues.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 276635     DOI: 10.1093/jnci/61.1.27

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  12 in total

1.  Update of PET and PET/CT for hepatobiliary and pancreatic malignancies.

Authors:  Dominique Delbeke; William H Martin
Journal:  HPB (Oxford)       Date:  2005       Impact factor: 3.647

Review 2.  18F-fluorodeoxyglucose PET scans in lung cancer.

Authors:  J M Hughes
Journal:  Thorax       Date:  1996-08       Impact factor: 9.139

Review 3.  Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose.

Authors:  P Rigo; P Paulus; B J Kaschten; R Hustinx; T Bury; G Jerusalem; T Benoit; J Foidart-Willems
Journal:  Eur J Nucl Med       Date:  1996-12

4.  18-F fluorodeoxyglucose uptake in positron emission tomography as a pathological grade predictor for renal clear cell carcinomas.

Authors:  Yoshifumi Noda; Masayuki Kanematsu; Satoshi Goshima; Natsuko Suzui; Yoshinobu Hirose; Kengo Matsunaga; Hironori Nishibori; Hiroshi Kondo; Haruo Watanabe; Hiroshi Kawada; Nobuyuki Kawai; Yukichi Tanahashi; Kyongtae T Bae
Journal:  Eur Radiol       Date:  2015-04-09       Impact factor: 5.315

5.  Limited value of positron emission tomography in treatment of pancreatic cancer: surgeon's view.

Authors:  R K Kasperk; K P Riesener; K Wilms; V Schumpelick
Journal:  World J Surg       Date:  2001-09       Impact factor: 3.352

6.  Impact of positron emission tomography on strategy in liver resection for primary and secondary liver tumors.

Authors:  B Böhm; M Voth; J Geoghegan; H Hellfritzsch; A Petrovich; J Scheele; D Gottschild
Journal:  J Cancer Res Clin Oncol       Date:  2004-02-06       Impact factor: 4.553

7.  Fluorodeoxyglucose PET imaging in the evaluation of gallbladder carcinoma and cholangiocarcinoma.

Authors:  Christopher D Anderson; Michael H Rice; C Wright Pinson; William C Chapman; Ravi S Chari; Dominique Delbeke
Journal:  J Gastrointest Surg       Date:  2004-01       Impact factor: 3.452

8.  Activity of hexokinase is increased by its interaction with hepatitis C virus protein NS5A.

Authors:  Christophe Ramière; Jonathan Rodriguez; Liviu S Enache; Vincent Lotteau; Patrice André; Olivier Diaz
Journal:  J Virol       Date:  2014-01-03       Impact factor: 5.103

9.  Use of benzodiazepines before (18)F-FDG-PET/CT dual-phase imaging does not decrease the efficacy of the study.

Authors:  Filiz Ozülker; Tamer Ozülker; Tevfik Ozpaçacı
Journal:  Indian J Nucl Med       Date:  2012-01

10.  Synthesis and evaluation of ortho-[18F] fluorocelecoxib for COX-2 cholangiocarcinoma imaging.

Authors:  Chi-Wei Chang; Chun-Nan Yeh; Yi-Hsiu Chung; Yong-Ren Chen; Shi-Wei Tien; Tsung-Wen Chen; Shiou-Shiow Farn; Ying-Cheng Huang; Chung-Shan Yu
Journal:  Drug Des Devel Ther       Date:  2018-05-24       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.